Metastatic Melanoma: Clinical Trials

5 trials for Metastatic Melanoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 terminated, 1 unknown. 5 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 15Completed 3, Terminated 1, Unknown 1

Follow Metastatic Melanoma: new trials by email Literature Review of Metastatic Melanoma trials Research Report on Metastatic Melanoma

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pilot Study of Nivolumab w/Ipilimumab or Relatlimab in Surgically Resectable Melanoma Brain Metastases
Nivolumab, Ipilimumab, Nivolumab + Relatlimab - Metastatic Melanoma, Metastasis to Brain
Early Phase 1CompletedH. Lee Moffitt Cancer Center and Research Institute12023-06-062026-04-06
18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases
Computed Tomography, 18F-FMAU, Multiparametric Magnetic Resonance Imaging - Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8
Early Phase 1CompletedUniversity of Southern California102021-02-152024-05-24
A Pilot Study Using Short-Term Cultured Anti-Tumor Autologous Lymphocytes
Tumor Infiltrating Lymphocytes, Nivolumab and Ipilimumab - Metastatic Melanoma
Early Phase 1TerminatedYale University62018-02-062022-07-25
Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma
Imiquimod, Biopsy, Pembrolizumab - Metastatic Melanoma, Stage IIIB Cutaneous Melanoma AJCC v7
Early Phase 1CompletedMayo Clinic72017-12-202026-03-19
Of 18F MEL050 Using PET/CT in Metastatic Melanoma
18F MEL050 - Metastatic Melanoma
Early Phase 1UnknownCooperative Research Centre for Biomedical Imaging Development122010-06-012012-06-15

Narrower conditions

Melanoma (5)  ·  Brain Neoplasms (2)  ·  Breast Neoplasms (1)  ·  Carcinoma, Renal Cell (1)  ·  Colonic Neoplasms (1)  ·  Glioma (1)  ·  Lung Neoplasms (1)

Broader conditions

Neoplasms (5)  ·  Neoplasms by Histologic Type (5)  ·  Neoplasms by Site (5)  ·  Neoplasms, Germ Cell and Embryonal (5)  ·  Neoplasms, Nerve Tissue (5)  ·  Neuroectodermal Tumors (5)  ·  Neuroendocrine Tumors (5)  ·  Nevi and Melanomas (5)  ·  Skin Diseases (5)  ·  Skin Neoplasms (5)  ·  Skin and Connective Tissue Diseases (5)  ·  Brain Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Central Nervous System Neoplasms (2)  ·  Nervous System Diseases (2)

Interventions

Ipilimumab (2)  ·  Magnetic Resonance Spectroscopy (2)  ·  Nivolumab (2)  ·  Biopsy (1)  ·  Imiquimod (1)  ·  Opdualag (1)  ·  clevudine (1)  ·  pembrolizumab (1)  ·  relatlimab (1)

Sponsors

Cooperative Research Centre for Biomedical Imaging Development (1)  ·  H. Lee Moffitt Cancer Center and Research Institute (1)  ·  Mayo Clinic (1)  ·  University of Southern California (1)  ·  Yale University (1)

Countries

United States (4)  ·  Australia (1)

Top investigators

Grant McArthur (1)  ·  Hossein Jadvar, MD (1)  ·  Peter Forsyth, MD (1)  ·  Ruqin Chen, MD, MB (1)  ·  Yolanda Pina, MD (1)

NIH funding

P30CA014089 (1)